Insulin sensitizers represent an important class of oral medications for the treatment of type 2 diabetes and work mainly by reducing insulin resistance, but a false scare with rosiglitatone led to prescribing changes for many healthcare providers.
[read_more text="read more" title="read more" url="https://tcoyd.org/2018/12/evaluating-type-2-medications-part-3-insulin-sensitizers/" align="left"]